Although IL-33 has been reported to play pro-tumorigenic or anti-tumorigenic roles in cancer development, both functions implicate IL-33 as a potent modulator of the TME by playing a major role in recruiting immune cells that impact tumor phenotype and malignancy. This evidence concerns the gene IL33 and neoplasm.